Back to search results

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

IsraelRecruiting

Conditions

Atypical Hemolytic-Uremic Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Clinical Trial Site, Aurora, Colorado, United States

    Dixon

  • Clinical Trial Site, Washington D.C., District of Columbia, United States

    Broome

  • Clinical Trial Site, Gainesville, Florida, United States

    Segal

  • Clinical Trial Site, Atlanta, Georgia, United States

    Greenbaum

  • Clinical Trial Site, Chicago, Illinois, United States

  • Clinical Trial Site, Boston, Massachusetts, United States

    Alenizi

  • Clinical Trial Site, St Louis, Missouri, United States

    Majerus

  • Clinical Trial Site, Winston-Salem, North Carolina, United States

  • Clinical Trial Site, Columbus, Ohio, United States

  • Clinical Trial Site 1, Westmead, New South Wales, Australia

    Durkan

  • Clinical Trial Site 2, Westmead, New South Wales, Australia

    Wong

  • Clinical Trial Site, Cairns, Queensland, Australia

    Mantha

  • Clinical Trial Site, Herston, Queensland, Australia

    Chandler

  • Clinical Trial Site, Woolloongabba, Queensland, Australia

    Isbel

  • Clinical Trial Site, Adelaide, South Australia, Australia

    Carroll

  • Clinical Trial Site, Heidelberg, Victoria, Australia

    Mount

  • Clinical Trial Site, Parkville, Victoria, Australia

    Hughes

  • Clinical Trial Site, Parkville, Victoria, Australia

    Kausman

  • Clinical Trial Site, Murdoch, Western Australia, Australia

    Abraham

  • Clinical Trial Site, Nedlands, Western Australia, Australia

  • Clinical Trial Site, Brussels, Belgium

  • Clinical Trial Site, Brussels, Belgium

    Broeders

  • Clinical Trial Site, Brussels, Belgium

    Pipeleers

  • Clinical Trial Site (Adult), Edegem, Belgium

    Massart

  • Clinical Trial Site (Pediatric), Edegem, Belgium

    Contact: Study coordinator (Van Hoeck)

  • Clinical Trial Site (pediatric), Ghent, Belgium

    Snauwaert

  • Clinical Trial Site (Adult), Leuven, Belgium

    Claes

  • Clinical Trial Site (pediatric), Leuven, Belgium

    Bockenhauer

  • Clinical Trial Site (Adult), Liège, Belgium

    Weekers

  • Clinical Trial Site (pediatric), Liège, Belgium

    Collard

  • Clinical Trial Site (adult), Woluwe-Saint-Lambert, Belgium

    Goffin

  • Clinical Trial Site (Pediatric), Woluwe-Saint-Lambert, Belgium

    Godefroid

  • Clinical Trial Site, London, Ontario, Canada

    Huang

  • Clinical Trial Site, Toronto, Ontario, Canada

    Licht

  • Clinical Trial Site, Montreal, Quebec, Canada

    Lapeyraque

  • Clinical Trial Site, Québec, Quebec, Canada

    Philibert

  • Clinical Trial Site, Odense, Denmark

    Dieperink

  • Clinical Trial Site 1, Amiens, France

    Djeddi

  • Clinical Trial Site 2, Amiens, France

    Choukroun

  • Clinical Trial Site, Angers, France

    Augusto

  • Clinical Trial Site, Bayonne, France

    Lacraz

  • Clinical Trial Site, Bordeaux, France

  • Clinical Trial Site, Brest, France

    LeMeur

  • Clinical Trial Site, Bron, France

    Sellier-LeClerc

  • Clinical Trial Site, Caen, France

    Chatelet-Pouliquen

  • Clinical Trial Site, Chambéry, France

    Bally

  • Clinical Trial Site, Clermont-Ferrand, France

    Heng

  • Clinical Trial Site, Dijon, France

    Legendre

  • Clinical Trial Site, Grenoble, France

    Carron

  • Clinical Trial Site, Le Kremlin-Bicêtre, France

    Snanoudj

  • Clinical Trial Site, Lille, France

    Provot

  • Clinical Trial Site, Lille, France

  • Clinical Trial Site, Lyon, France

    Jolivot

  • Clinical Trial Site, Marseille, France

    Rousset-Rouviere

  • Clinical Trial Site, Montpellier, France

    Fila

  • Clinical Trial Site 1, Nancy, France

    Frimat

  • Clinical Trial Site, Nancy, France

    Vrillon

  • Clinical Trial Site, Nantes, France

    Roussey

  • Clinical Trial Site 1, Nantes, France

    Ville

  • Clinical Trial Site, Nice, France

    Seitz-Polski

  • Clinical Trial Site 2, Paris, France

    Legendre

  • Clinical Trial Site 4, Paris, France

    Thervet

  • Clinical Trial Site 1, Paris, France

    Hogan

  • Clinical Trial Site 5, Paris, France

    Boyer

  • Clinical Trial Site 3, Paris, France

    Mesnard

  • Clinical Trial Site, Perpignan, France

    Vela

  • Clinical Trial Site, Poitiers, France

    Bridoux

  • Clinical Trial Site, Pontoise, France

    Devaud

  • Clinical Trial Site, Rennes, France

    Taque

  • Clinical Trial Site, Rennes, France

    Martins

  • Clinical Trial Site 1, Rouen, France

    Lebourg

  • Clinical Trial Site 2, Rouen, France

    Louillet

  • Clinical Trial Site 1, Strasbourg, France

    Moulin

  • Clinical Trial Site 2, Strasbourg, France

    Krummel

  • Clinical Trial Site, Toulouse, France

    Kamar

  • Clinical Trial Site, Toulouse, France

    Decramer

  • Clinical Trial Site, Tours, France

    Halimi

  • Clinical Trial Site, Valenciennes, France

    Ulrich

  • Clinical Trial Site, Essen, Germany

    Gackler

  • Clinical Trial Site 1, Hanover, Germany

    Schmidt-Ott

  • Clinical Trial Site 2, Hanover, Germany

    Kanzelmeyer

  • Clinical Trial Site, Heidelberg, Germany

    Wuehl

  • Clinical Trial Site, Lübeck, Germany

  • Clinical Trial Site, Münster, Germany

    Konrad

  • Clinical Trial Site, Tübingen, Germany

  • Clinical Trial Site, Beersheba, Israel

    Schreiber

  • Clinical Trial Site 1, Bari, Italy

    Giordano

  • Clinical Trial Site 2, Bari, Italy

    Gesualdo

  • Clinical Trial Site, Florence, Italy

    Cirami

  • Clinical Trial Site, Genova, Italy

    Magnasco

  • Clinical Trial Site 1, Milan, Italy

    Ardissino

  • Clinical Trial Site 2, Milan, Italy

    Verdesca

  • Clinical Trial Site, Milan, Italy

    Ravera

  • Clinical Trial Site, Roma, Italy

    Vivarelli

  • Clinical Trial Site, Torino, Italy

  • Clinical Trial Site, Lodz, Poland

    Nowicki

  • Clinical Trial Site, Lodz, Poland

    Pawlak-Bratkowska

  • Clinical Trial Site 1, Moscow, Russia

  • Clinical Trial Site 2, Moscow, Russia

  • Clinical Trial Site, Saint Petersburg, Russia

  • Clinical Trial Site, Dongan, Chungcheongnam-do, South Korea

    Gil

  • Clinical Trial Site, Seoul, Dongnam-ro, South Korea

    Jung

  • Clinical Trial Site, Anyang-si, Gyeonggi-do, South Korea

  • Clinical Trial Site, Goyang-si, Gyeonggi-do, South Korea

  • Clinical Trial Site, Daegu, Hyeonchung-ro, South Korea

    Do

  • Clinical Trial Site, Gwangju, Jebong Ro, South Korea

    Bae

  • Clinical Trial Site, Daegu, South Korea

    Kim

  • Clinical Trial Site 1, Gyeonggi-do, South Korea

  • Clinical Trial Site 2, Gyeonggi-do, South Korea

    Contact: Study coordinator (Young Chong)

  • Clinical Trial Site, Jeju-do, South Korea

  • Clinical Trial Site, Jeollabuk-do, South Korea

  • Clinical Trial Site 2, Seoul, South Korea

    Kim

  • Clinical Trial Site 3, Seoul, South Korea

    Kim

  • Clinical Trial Site 5, Seoul, South Korea

    Contact: Study coordinator (Hoon Lee)

  • Clinical Trial Site 6, Seoul, South Korea

    Jang

  • Clinical Trial Site 7, Seoul, South Korea

    Mun

  • Clinical Trial Site 4, Seoul, South Korea

    Contact: Study coordinator (Joo Kwon)

  • Clinical Trial Site 1, Seoul, South Korea

    Contact: Study coordinator (Gyung Kang)

  • Clinical Trial Site 1, Barcelona, Spain

    Ariceta

  • Clinical Trial Site 2, Barcelona, Spain

    Ramos

  • Clinical Trial Site, Pamplona, Spain

    Manrique

  • Clinical Trial Site, Seville, Spain

  • Clinical Trial Site, Basel, Switzerland

  • Clinical Trial Site, Bern, Switzerland

  • Clinical Trial Site, Surich, Switzerland

  • Clinical Trial Site, Kaohsiung City, Taiwan

    Chiou

  • Clinical Trial Site, New Taipei City, Taiwan

    Tsai

  • Clinical Trial Site, Taichung, Taiwan

    Huang

  • Clinical Trial Site, Taoyuan, Taiwan

    Tseng

  • Clinical Trial Site, Ankara, Turkey (Türkiye)

    Derici

  • Clinical Trial Site, Istanbul, Turkey (Türkiye)

    Yildiz

  • Clinical Trial Site, Kayseri, Turkey (Türkiye)

    Tokgoz

  • Clinical Trial Site, Cardiff, United Kingdom

    Griffin

  • Clinical Trial Site, Exeter, United Kingdom

    Bingham

  • Clinical Trial Site, London, United Kingdom

    Gale

  • Clinical Trial Site, London, United Kingdom

    Scully

  • Clinical Trial Site, London, United Kingdom

    Marks

  • Clinical Trial Site, Manchester, United Kingdom

    Shenoy

  • Clinical Trial Site, Newcastle, United Kingdom

  • Clinical Trial Site, Southampton, United Kingdom

    Gilbert

  • Clinical Trial Site, Wales, United Kingdom

    Mikhail
Study leads

  • Nuria Saval

    Study Director

    Alexion Pharmaceuticals, Inc.

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)